Four leading drugmakers seeking to scuttle Medicare’s drug pricing program will have their day in federal court Thursday to defend a gamut of legal challenges against the scheme.
The four-and-a-half hour long meeting will lay out the legal battle between the pharmaceutical industry ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.